Answers are grounded in this paper and cite their sources.
The preparation and antifungal properties of cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl-methyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine (I) are described. Ketoconazole has, at low oral doses, a high in vivi activity against vaginal candidosis in rats and against cutaneous candidosis in guinea pigs.
No takes yet. Share an insight, caveat, or question.
Heeres et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: